Cell imaging system
Cell3iMager duos2 Automation system
In-vitro microelectrode array system
“The most sensitive microelectrode array system for in vitro extracellular electrophysiology”
The MED64 Systems are user-friendly microelectrode array (MEA) system for in vitro extracellular electrophysiology. Acute or cultured biological preparations are placed or grown directly on a grid of planar microelectrodes , which serve dual purpose: record of field potential at each electrode and deliver stimulation via any electrode.
The MED64 features with the industry’s most sensitive MEA system due to its lowest-impedance electrodes. Started by Panasonic, the MED64 has been on market for 20 years with hundreds of users and publications worldwide.
The MED64 related products are produced by AlphaMED Scientific, Inc., a group company of SCREEN Holdings.
MED64-Basic
Basic system for both acute and
cultured applications
MED64-Quad II
Medium-throughput system for both
acute and cultured applications
MED64-Allegro
Medium-throughput system with
multiple wells
MED64-Plex4/8
Medium-throughput system for recording from
64 electrodes on 4 or 8 samples
Applications
Cell3iMager series offer a lot of applications
that can enhance your assays
News
CONTACT
OUR ADDRESS
SCREEN Holdings Co., Ltd. (Japan)
Furukawa-cho 322, Hazukashi, Fushimi-ku, Kyoto 612-8486
+81-75-931-7771
(Inquiry counter for Japan and Asian countries)
SCREEN North America Holdings, Inc. (USA)
5110 Tollview Drive, Rolling Meadows, IL 60008, U.S.A.
+1-847-870-740
URL: https://www.screenlifescience.com/
(Inquiry counter for US and EU)